HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Static and fatigue properties of two new low-viscosity PMMA bone cements improved by vacuum mixing.

Abstract
With the objectives of reducing toxicity and improving the mechanical properties of the prior Sulfix-6 cement, a new low-viscosity bone cement with a new catalyst (Sulfix-60), and a gentamycin containing cement (Allofix-G) were developed. Although static strength could be improved in comparison with the older Sulfix-6 cement, investigations regarding improved fatigue strength and the influence of vacuum mixing on the mechanical properties were missing. Dynamic weakness was the major disadvantage of the older Sulfix-6 cement. To investigate fatigue strength specimens of the new bone cements were tested with load guiding until breakage or 20 million cycles. In the three series, hand mixing, vacuum mixing, and vacuum mixing with additional pressurization were performed, respectively. Vacuum mixing led to increased fatigue stability from 6.3 to 9.1 MPa for Sulfix-60, and from 6.3 to 8.2 MPa for Allofix-G. Additional compression had no significant effect. A 200% increased fatigue strength was detectable in comparison with the older cement. In the four-point bending test, similar results were found. It could be proved that an increased polymerization rate achieved with the use of the new catalyst was responsible for the improved mechanical properties of the new bone cement Sulfix-60.
AuthorsE W Fritsch
JournalJournal of biomedical materials research (J Biomed Mater Res) Vol. 31 Issue 4 Pg. 451-6 (Aug 1996) ISSN: 0021-9304 [Print] United States
PMID8836840 (Publication Type: Journal Article)
Chemical References
  • Bone Cements
  • Methylmethacrylates
Topics
  • Bone Cements (standards)
  • Methylmethacrylates (chemistry)
  • Stress, Mechanical
  • Vacuum
  • Viscosity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: